Goodwill E-Health Info Co., Ltd.

SSE:688246.SS

28.99 (CNY) • At close May 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Revenue 101.199116.195175.272176.81122.56165.443245.756184.452107.505261.627203.404153.8998.028267.707174.191136.85673.186233.33725.663
Cost of Revenue 57.964131.76194.62691.86264.77465.228111.02699.88159.181122.77999.572.4355.86115.18797.582105.31737.08101.117.466
Gross Profit 43.235-15.56680.64684.94757.786100.215134.72984.57148.324138.848103.90481.46142.168152.5276.60931.53936.106132.2378.197
Gross Profit Ratio 0.427-0.1340.460.480.4710.6060.5480.4580.450.5310.5110.5290.430.570.440.230.4930.5670.319
Reseach & Development Expenses 34.429040.43343.61232.07817.63532.31450.28744.68923.45840.16547.15848.01128.98832.54133.74530.15213.91326.606
General & Administrative Expenses 21.822053.322-7.23720.939-42.62948.1373.26523.091-37.56153.837-11.19121.9388.0732.44912.93515.2795.6462.279
Selling & Marketing Expenses 20.38054.89124.37724.87826.62627.31229.67521.63321.88625.0224.68125.84126.34326.91729.48421.93724.12316.386
SG&A 42.202-79.78108.21360.03945.817-16.00375.44932.9444.725-15.67578.85713.48947.77934.41529.36655.04140.8429.76918.664
Other Expenses 4.739192.5722.23-10.02-0.3250.033-0.024-0.022-3.51647.689-38.72726.688-3.106-0.02-0.02-47.443-103.453-0.039-0.381
Operating Expenses 81.37140.706101.624113.67173.6547.1879.696102.35685.89855.47280.29487.33592.68355.08669.37-47.443-103.45347.41552.571
Operating Income -38.135-129.334-20.978-28.724-18.78725.58440.824-19.733-40.2466.18815.967-5.875-50.51574.05-1.307-15.904-30.26778.231-49.12
Operating Income Ratio -0.377-1.113-0.12-0.162-0.1530.1550.166-0.107-0.3740.2530.078-0.038-0.5150.277-0.008-0.116-0.4140.335-1.914
Total Other Income Expenses Net -0.028-0.015-0.669-0.029-0.3251.441-0.024-0.0220.0061.445-0.3-0.833-0.039-0.02-0.02-0.097-0.007-0.039-0.381
Income Before Tax -38.163-129.35-21.647-32.828-19.11225.6240.8-19.755-40.23467.63215.667-10.684-45.24474.03-1.327-16.001-30.27478.192-49.502
Income Before Tax Ratio -0.377-1.113-0.124-0.186-0.1560.1550.166-0.107-0.3740.2590.077-0.069-0.4620.277-0.008-0.117-0.4140.335-1.929
Income Tax Expense -12.729-31.343-6.698-11.813-3.10920.3070.63-12.057-8.887.961-5.636-7.475-8.215.237-2.28683.374-113.55812.06-10.542
Net Income -17.433-98.006-13.787-15.622-11.85136.1541.194-0.502-31.35566.54921.303-3.21-37.03372.2164.568-6.977-20.16964.551-36.837
Net Income Ratio -0.172-0.843-0.079-0.088-0.0970.2190.168-0.003-0.2920.2540.105-0.021-0.3780.270.026-0.051-0.2760.277-1.435
EPS -0.13-0.79-0.1-0.11-0.090.270.3-0.004-0.230.480.15-0.024-0.270.520.045-0.068-0.20.63-0.36
EPS Diluted -0.13-0.79-0.1-0.11-0.090.270.3-0.004-0.230.480.15-0.023-0.270.520.045-0.068-0.20.63-0.36
EBITDA -35.578-129.334-19.458-23.318-17.64234.86647.48-13.842-34.08373.79415.988-4.667-39.10679.6093.908-11.735-26.19679.52-48.745
EBITDA Ratio -0.352-1.113-0.111-0.132-0.1440.2110.193-0.075-0.3170.2820.079-0.03-0.3990.2970.022-0.086-0.3580.341-1.899